124 related articles for article (PubMed ID: 140848)
1. The halogenated 8-hydroxyquinolines.
Neldner KH
Int J Dermatol; 1977 May; 16(4):267-73. PubMed ID: 140848
[No Abstract] [Full Text] [Related]
2. Oxyquinoline toxicity.
Soffer M; Basdevant A; Sarragoussi JJ; Raison J; Guy-Grand B
Lancet; 1983 Mar; 1(8326 Pt 1):709. PubMed ID: 6132067
[No Abstract] [Full Text] [Related]
3. [Allergies to 8-hydroxyquinoline derivatives].
Hutzler D; Pevny I
Derm Beruf Umwelt; 1988; 36(3):86-90. PubMed ID: 2970376
[TBL] [Abstract][Full Text] [Related]
4. [8-Hydroxyquinoline derivatives in the treatment of patients with onychomycoses].
Butareva TA; Kukushkin AM; Unzhakov VP; Nemkaeva RM
Vestn Dermatol Venerol; 1986; (12):50-3. PubMed ID: 2951932
[No Abstract] [Full Text] [Related]
5. More on S.M.O.N.
Lancet; 1971 Dec; 2(7736):1244. PubMed ID: 4143604
[No Abstract] [Full Text] [Related]
6. [Contribution to the therapy of acute and chronic enteritis, with special reference to cases due to dysmicrobialism].
Giuffrida G
Clin Ter; 1966 Aug; 38(4):315-29. PubMed ID: 4229941
[No Abstract] [Full Text] [Related]
7. The neurotoxicity of the halogenated hydroxyquinolines. A commentary.
Oakley GP
JAMA; 1973 Jul; 225(4):395-7. PubMed ID: 4270059
[No Abstract] [Full Text] [Related]
8. American Academy of Pediatrics Committee on Drugs: Clioquinol (iodochlorhydroxyquin, vioform) and iodoquinol (diiodohydroxyquin): blindness and neuropathy.
Pediatrics; 1990 Nov; 86(5):797-8. PubMed ID: 2146587
[No Abstract] [Full Text] [Related]
9. [Spasmolytic and anti-inflammatory activity of 8-hydroxyquinolines].
Zaks AS; Zil'ber AL; Kapitonenko TA
Farmakol Toksikol; 1984; 47(5):44-7. PubMed ID: 6238840
[TBL] [Abstract][Full Text] [Related]
10. Contact sensitivity to chlorquinaldol.
Myatt AE; Beck MH
Contact Dermatitis; 1983 Nov; 9(6):523. PubMed ID: 6228382
[No Abstract] [Full Text] [Related]
11. [Indices for the user of halogenized 8-hydroxyquinolines in dermatology].
Levkov AA; Dubiaga AN
Vestn Dermatol Venerol; 1977 Feb; (2):69-72. PubMed ID: 404774
[No Abstract] [Full Text] [Related]
12. Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols.
Sturtevant FM
Pediatrics; 1980 Mar; 65(3):610-3. PubMed ID: 6444713
[TBL] [Abstract][Full Text] [Related]
13. [Use of isoniazid with nitrofuran and 5-NHQ derivatives in experimental tuberculosis].
Il'ina TB; Vishnevskiĭ BI; Efremova IIa; Vavilin GI
Probl Tuberk; 1976; (8):51-5. PubMed ID: 826902
[No Abstract] [Full Text] [Related]
14. [Experience with the preparation 5-NOK in a clinical trial. I. Microbiological investigation (author's transl].
Hausnerová S; Tesarová Z; Uhlír O
Cesk Epidemiol Mikrobiol Imunol; 1975 Mar; 24(2):97-101. PubMed ID: 124227
[No Abstract] [Full Text] [Related]
15. Sensitivity to clioquinol and chlorquinaldol in the quinoline mix.
Agner T; Menné T
Contact Dermatitis; 1993 Sep; 29(3):163. PubMed ID: 8222638
[No Abstract] [Full Text] [Related]
16. [5-Nok in the treatment of candidiasis].
Ljubojević S; Perinović M; Kesić V
Med Arh; 1975; 29(6):643-4. PubMed ID: 814373
[No Abstract] [Full Text] [Related]
17. [Clioquinol].
Jurkiewicz A; Zeitune JM; Nobre MR; Endo RM; Sanvito WL
Rev Paul Med; 1985; 103(6):297-300. PubMed ID: 2945249
[No Abstract] [Full Text] [Related]
18. [8-hydroxyquinoline derivatives as wide-spectrum chemotherapeutic agents].
Chernomordik AB
Klin Med (Mosk); 1984 Feb; 62(2):133-6. PubMed ID: 6423880
[No Abstract] [Full Text] [Related]
19. Blindness and neuropathy from diiodohydroxyquin-like drugs. Committee on drugs.
Pediatrics; 1974 Sep; 54(3):378-9. PubMed ID: 4278011
[No Abstract] [Full Text] [Related]
20. [Recent research on derivatives of 8-oxyquinoline. New 7-arylglyoxylidenehydrazinomethyl-8-oxyquinolines and 5-chloro-7-arylglyoxylidenehydrazinomethyl-8-oxyquinolines].
Tajana A; Nardi D; Veronese M
Boll Chim Farm; 1975 Aug; 114(8):440-4. PubMed ID: 810149
[No Abstract] [Full Text] [Related]
[Next] [New Search]
